Application of novel machine learning model in [68Ga] GaPSMA-11 PET/CT: Predicting survival in oligometastatic prostate cancer patients

被引：0
|
作者：
Dell'Oro, M. [1 ]
Ebert, M. A. [2 ]
Ong, J. [3 ]
McCarthy, M. [3 ]
Tang, C. [2 ]
Francis, R. J. [4 ]
机构：
[1] Univ Western Australia, Sch Med, Australian Ctr Quantitat Imaging, Perth, WA, Australia
[2] Sir Charles Gairdner Hosp, Dept Radiat Oncol, Nedlands, WA, Australia
[3] Fiona Stanley Hosp, Dept Nucl Med, Perth, WA, Australia
[4] Sir Charles Gairdner Hosp, Dept Nucl Med, Nedlands, WA, Australia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2747
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1797P
引用
收藏
页码：S972 / S972
页数：1
相关论文
共 50 条
  • [1] First experiences with late acquisition [68Ga]GaPSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer
    Alberts, I.
    Prenosil, G.
    Mingels, C.
    Bohn, K.
    Viscione, M.
    Sari, H.
    Rominger, A.
    Afhsar-Oromieh, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S264 - S265
  • [2] Application of [68Ga]PSMA PET/CT in Diagnosis and Management of Prostate Cancer Patients
    Dadgar, Habibollah
    Emami, Farshad
    Norouzbeigi, Nasim
    Vafaee, Manouchehr Seyedi
    Jafari, Esmail
    Gholamrezanezhad, Ali
    Assadi, Majid
    Ahmadzadehfar, Hojjat
    MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (04) : 1062 - 1069
  • [3] Application of [68Ga]PSMA PET/CT in Diagnosis and Management of Prostate Cancer Patients
    Habibollah Dadgar
    Farshad Emami
    Nasim Norouzbeigi
    Manouchehr Seyedi Vafaee
    Esmail Jafari
    Ali Gholamrezanezhad
    Majid Assadi
    Hojjat Ahmadzadehfar
    Molecular Imaging and Biology, 2020, 22 : 1062 - 1069
  • [4] Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer
    Soydal, Cigdem
    Urun, Yuksel
    Suer, Evren
    Nak, Demet
    Ozkan, Elgin
    Kucuk, Nuriye O.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (02): : 226 - 230
  • [5] 68GaPSMA11 PET/CT in prostate cancer patients with biochemical recurrence: PET positivity predictors
    Parise, R.
    Bartoncini, S.
    Guarneri, A.
    Deandreis, D.
    Lillaz, B.
    Solla, S. D.
    Spinelli, L.
    Nicolotti, D.
    Pilati, E.
    Bello, M.
    Passera, R.
    Gontero, P.
    Bisi, G.
    Ricardi, U.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S438 - S438
  • [6] The impact of (68Ga)-Ga-PSMA-11 PET/CT in primary staging of prostate cancer
    Weitzer, F.
    Pernthaler, B.
    Plhak, E.
    Riedl, R.
    Aigner, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S458 - S458
  • [7] 68Ga PSMA PET/CT in Restaging of Prostate Cancer Patients with Biochemical Recurrence
    Seniaray, Nikhil
    Verma, Ritu
    Khanna, Sudhir
    Pruthi, Ankur
    Belho, Ethel
    Mahajan, Harsh
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [8] HTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer
    Pozzo, Lorena
    Monteiro, Lucilena Rebelo
    Cerci, Juliano Julio
    Fanti, Stefano
    Negro, Antonella
    Trindade, Evelinda
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (01) : 7 - 20
  • [9] (68Ga) gallium-PSMA PET/CT in the evaluation of prostate cancer patients
    Bal, C.
    Ballal, S.
    Tripati, M.
    Chakraborty, P.
    Thakral, P.
    Arora, G.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56
  • [10] HTA in nuclear medicine: [68Ga]PSMA PET/CT for patients with prostate cancer
    Lorena Pozzo
    Lucilena Rebelo Monteiro
    Juliano Julio Cerci
    Stefano Fanti
    Antonella Negro
    Evelinda Trindade
    Clinical and Translational Imaging, 2019, 7 : 7 - 20
12345